Novel 3-spirocyclic indolyl derivatives useful as ORL-1 receptor modulators
申请人:Battista A. Kathleen
公开号:US20070112016A1
公开(公告)日:2007-05-17
The present invention is directed to novel 3-spirocyclic indolyl derivatives, pharmaceutical compositions containing them and their use in the treatment of disorders and conditions modulated by the ORL-1 receptor.